Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives

Organic and Biomolecular Chemistry

Volumn 3, Issue 14, 2005, Pages 2657-2660

  Kaffy, Julia ^a   Pontikis, Renée ^a   Florent, Jean Claude ^a   Monneret, Claude ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CHEMICAL BONDS; HYDRIDES; MOLECULAR STRUCTURE; POLYMERIZATION; STEREOCHEMISTRY; SYNTHESIS (CHEMICAL);

A-4 DERIVATIVES; BIOLOGICAL EVALUATION; TUBULIN POLYMERIZATION; VINYLOGOUS COMBRETASTAIN;

DERIVATIVES;

ANTINEOPLASTIC AGENT; COMBRETASTATIN A 4; COMBRETASTATIN A-4; STILBENE DERIVATIVE; TUBULIN; VINYL DERIVATIVE;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG SCREENING; HUMAN; STEREOISOMERISM; SWINE; SYNTHESIS; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MOLECULAR STRUCTURE; STEREOISOMERISM; STILBENES; SWINE; TUBULIN; VINYL COMPOUNDS;

EID: 23044492692     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/b505955k     Document Type: Article

References (32)

1. G. R. Pettit, S. B. Singh, E. Hamel, C. M. Lin, D. S. Alberts and D. Garcia-Kendall, Experientia, 1989, 45, 209-211.
2. C. M. Lin, S. B. Singh, P. S. Chu, R. O. Dempcy, J. M. Schmidt, G. R. Pettit and E. Hamel, Mol. Pharmacol., 1988, 34, 200-208.
3. G. G. Dark, S. A. Hill, V. E. Prise, G. M. Tozer, G. R. Pettit and D. J. Chaplin, Cancer Res., 1997, 57, 1829-1834.
4. G. M. Tozer, V. E. Prise, J. Wilson, M. Cemazar, S. Shan, M. W. Dewhirst, P. R. Barber, B. Vojnovic and D. J. Chaplin, Cancer Res., 2001, 61, 6413-6422.
5. C. Kanthou and G. M. Tozer, Blood, 2002, 99, 2060-2069.
6. C. M. L. West and P. Price, Anti-Cancer Drugs, 2004, 15, 179-187.
7. K. Hori and S. Saito, Br. J. Cancer, 2003, 89, 1334-1344.
8. M. Guffroy, C. Dally, P. Vrignaud, E. Beys and M.-C. Bissery, Proc. Am. Assoc. Cancer Res., 2004, 45, abstract 5438.
9. For recent reviews on vascular disrupting agents see: (a) D. W. Siemann, D. J. Chaplin and M. R. Horsman, Cancer, 2004, 100, 2491-2499;
10. (b) P. E. Thorpe, Clin. Cancer Res., 2004, 10, 415-427;
11. (c) L. R. Kelland, Curr. Cancer Therapy Rev., 2005, 1, 1-9.
12. (a) N.-H. Nam, Curr. Med. Chem., 2003, 10, 1697-1722 and references cited therein;
13. (b) A. Cirla and J. Mann, Nat. Prod. Rep., 2003, 20, 558-564;
14. (c) K. Gaukroger, J. A. Hadfield, N. J. Lawrence, S. Nolan and A. T. McGown, Org. Biomol. Chem., 2003, 1, 3033-3037;
15. (d) J.-P. Liou, Y.-L. Chang, F.-M. Kuo, C.-W. Chang, H.-Y. Tseng, C.-C. Wang, Y.-N. Yang, J.-Y. Chang, S.-J. Lee and H.-P. Hsieh, J. Med. Chem., 2004, 47, 4247-4257;
16. (e) L. Sun, N. I. Vasilevich, J. A. Fuselier, S. J. Hocart and D. H. Coy, Bioorg. Med. Chem. Lett., 2004, 14, 2041-2046;
17. (f) J. Kaffy, C. Monneret, P. Mailliet, A. Commerçon and R. Pontikis, Tetrahedron Lett., 2004, 45, 3359-3362;
18. (g) G. De Martine, G. La Regina, A. Coluccia, M. C. Edler, M. C. Barbera, A. Brancale, E. Wilcox, E. Hamel, M. Artico and R. Silvestri, J. Med. Chem., 2004, 47, 6120-6123;
19. (h) A. B. S. Maya, C. Pérez-Melero, C. Mateo, D. Alonso, J. L. Fernández, C. Gajate, F. Mollinedo, R. Peláez, E. Caballero and M. Medarde, J. Med. Chem., 2005, 48, 556-568;
20. (i) D. Simoni, G. Grisolia, G. Giannini, M. Roberti, R. Rondanin, L. Piccagli, R. Baruchello, M. Rossi, R. Romagnoli, F. P. Invidiata, S. Grimaudo, M. K. Jung, E. Hamel, N. Gebbia, L. Crosta, V. Abbadessa, A. Di Cristina, L. Dusonchet, M. Meli and M. Tolomeo, J. Med. Chem., 2005, 48, 723-736.
21. A. T. McGown and B. W. Fox, Anti-Cancer Drug Des., 1989, 3, 249-254.
22. N. Miyaura and A. Suzuki, Chem. Rev., 1995, 95, 2457-2483.
23. N. J. Lawrence, F. A. Ghani, L. A. Hepworth, J. A. Hadfield and A. T. McGown, Synthesis, 1999, 9, 1656-1660.
24. K. Gaukroger, J. A. Hadfield, L. A. Hepworth, N. J. Lawrence and A. T. McGown, J. Org. Chem., 2001, 66, 8135-8138.
25. H. C. Brown and S. K. Gupta, J. Am. Chem. Soc., 1972, 94, 4370-4371.
26. E. Corey and P. L. Fuchs, Tetrahedron Lett., 1972, 36, 3769-3772.
27. J. Uenishi, R. Kawahama, Y. Shiga and O. Yonemistu, Tetrahedron Lett., 1996, 37, 6759-6962.
28. N. Miyaura, H. Suginome and A. Suzuki, Tetrahedron, 1983, 39, 3271-3277.
29. H.-G. Herz, M. J. Queiroz and G. Maas, Synthesis, 1999, 6, 1013-1016.
30. HyperChem version 7.0, (HyperCube Inc.).
31. 3.
32. C. Combeau, J. Provost, F. Lancelin, Y. Tournoux, F. Prod'homme, F. Herman, F. Lavelle, J. Leboul and M. Vuilhorgne, Mol. Pharmacol., 2000, 57, 553-563.